Jazz Pharmaceuticals PLC (JAZZ) earnings · rev $4.27B
These earnings events as JSON? API free 100/dayJazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
This JAZZ earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported JAZZ revenue for 2025-12-31 was $4.27B. Net income was -$356.1M. Revenue was up 4.9% from 2024-12-31 to 2025-12-31. JAZZ currently screens at market cap $14.97B.
When the next JAZZ 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 4.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full JAZZ research stays on the stock page; the tape stays on the quote page.
JAZZ earnings FAQ
What are JAZZ's latest revenue and net income?
Latest cached Jazz Pharmaceuticals PLC (JAZZ) revenue for Dec 31, 2025 was $4.27B. Net income was -$356.1M. Statements: https://lician.com/financials/jazz
What is JAZZ's latest diluted EPS?
Latest cached Jazz Pharmaceuticals PLC (JAZZ) diluted EPS for Dec 31, 2025 was -$5.84.
What period does the latest JAZZ earnings print cover?
The latest cached Jazz Pharmaceuticals PLC (JAZZ) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did JAZZ revenue change from the prior cached period?
Cached Jazz Pharmaceuticals PLC (JAZZ) revenue was up 4.9% from $4.07B (Dec 31, 2024) to $4.27B (Dec 31, 2025). Statements: https://lician.com/financials/jazz
Where are JAZZ earnings listed?
Cached earnings facts for Jazz Pharmaceuticals PLC (JAZZ) are listed at https://lician.com/earnings/jazz. Statements: https://lician.com/financials/jazz
Not investment advice.